SCHEMBL8434815

SCHEMBL8434815

COc1ccc(OCc2ccccc2)c(C#CCOc2ccc3ncncc3c2)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.53
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
ERBB2 P04626 1/20 0.40
MAOB P27338 2/20 0.40
LRRK2 Q5S007 1/20 0.39
GRM5 P41594 3/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP2E1 P05181 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
KIT P10721 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8438744 0.78 EGFR (0.58) EGFRPDGFRBPDGFRAKIT
SCHEMBL8434822 0.73 PDGFRB (0.42) EGFRPDGFRBPDGFRAHDAC8ERBB2
SCHEMBL7796162 0.73 EGFR (0.63) EGFRPDGFRBPDGFRA
SCHEMBL3372138 0.73 EGFR (1.00) EGFRPDGFRBPDGFRANPC1RAB9A
Biphenyl SCHEMBL28023494 0.72 EGFR (0.79) EGFRPDGFRBPDGFRANPC1RAB9A
Hydrochloric Acid SCHEMBL28032872 0.71 EGFR (0.96) EGFRPDGFRBPDGFRANPC1RAB9A
SCHEMBL30555608 0.70 PDGFRB (0.65) EGFRPDGFRBPDGFRAKIT
SCHEMBL7804549 0.70 EGFR (0.51) EGFRPDGFRBHDAC8ERBB2MAOB
SCHEMBL22498605 0.70 MAOB (0.70) MAOBNPC1RAB9A
Hydrochloric Acid SCHEMBL28188205 0.69 PDGFRB (0.64) EGFRPDGFRBPDGFRAKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990116-A USE IN PREVENTION OR TREATMENT OF INFLAMMATORY AND PROLIFERATIVE SKIN DISEASES AND CANCER; COMPOUNDS SUCH AS 6-(2-(2,5-DIMETHOXYPHENYL)ETHYL)-4-ETHYL-QUINAZOLINE NOVARTIS AG (CH) 1999-11-23 US disclosed